Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Transfection Reagents and Equipment Global Market Report 2023: Growing Demand for Synthetic Genes Fuels Sector
March 21, 2023 06:53 ET
|
Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Market by Product, by Method, by Application, by End User, and by Region - Global Forecast to 2022-2033" report...
Global Non-Viral Transfection Reagents and Systems Market 2023 to 2035: Featuring Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene and OZ Biosciences Among Others
March 16, 2023 06:38 ET
|
Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents and Systems Market (2nd Edition) by Type of Non-Viral Transfection Method, End-User, Application Areas and Key...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments
March 13, 2023 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $38.0 Million, a 21% Increase Compared to Prior Year Quarter -- -- Signed $67 Million in Net New Business Orders Resulting in a Backlog of $176 million, an...
T-cell Therapy Global Market Report 2023: Rising Global Investments in Gene and Cell Therapy Arena Presents Opportunities
March 13, 2023 05:18 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "T-cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), By Indication...
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023
March 06, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Worldwide Omics Lab Services Industry to 2028: Featuring Agilent Technologies, Qiagen, Quest Diagnostics, Illumina and BGI Among Others
March 06, 2023 10:03 ET
|
Research and Markets
Dublin, March 06, 2023 (GLOBE NEWSWIRE) -- The "Global Omics Lab Services Market Size, Share & Industry Trends Analysis Report By Business (Diagnostic Labs, Research Institutes, and Hospitals),...
Global Advanced Therapy Medicinal Products CDMO Market Report 2023: Rising Need for CDMOS Due to Increasing Number of ATMP Clinical Trials
February 28, 2023 08:18 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product, By Phase, By...
Plasmid DNA Manufacturing Global Market Report 2023: Inorganic Growth Strategies Continue to Bolster Sector Expansion
February 28, 2023 07:38 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Plasmid DNA Manufacturing Market, By Product Type, By Grade, By Application, By Manufacturing Type, By Development Phase, By Region - Size, Share,...
Global Cell & Gene Therapy Business and Investment Opportunities Q1 2023 Update: Mergers and Acquisitions Continue to Dominate Growth Prospects
February 24, 2023 08:53 ET
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Advances in Gene Editing Technologies in Healthcare, 2023 Research Report - Next-Generation Genome Editing Tools and Improved Delivery Are Bolstering Gene Editing Therapeutics and Diagnostics
February 10, 2023 10:53 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs are...